FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4583011000001101: Meggezones 16mg pastilles (Schering-Plough Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17952501000001114 Meggezones 16mg pastilles (Schering-Plough Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
89309701000001113 Meggezones 16mg pastilles (Bayer Plc) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Meggezones 16mg pastilles (Schering-Plough Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Meggezones 16mg pastilles (Schering-Plough Ltd) Is a Menthol 16mg pastilles true Inferred relationship Existential restriction modifier
Meggezones 16mg pastilles (Schering-Plough Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Meggezones 16mg pastilles (Schering-Plough Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Meggezones 16mg pastilles (Schering-Plough Ltd) Has active ingredient Menthol true Inferred relationship Existential restriction modifier
Meggezones 16mg pastilles (Schering-Plough Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Meggezones 16mg pastilles (Schering-Plough Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Meggezones 16mg pastilles (Schering-Plough Ltd) Has manufactured dose form Pastille false Inferred relationship Existential restriction modifier
Meggezones 16mg pastilles (Schering-Plough Ltd) Is a Meggezones true Inferred relationship Existential restriction modifier
Meggezones 16mg pastilles (Schering-Plough Ltd) Has specific active ingredient Menthol true Inferred relationship Existential restriction modifier
Meggezones 16mg pastilles (Schering-Plough Ltd) Has dispensed dose form Pastille true Inferred relationship Existential restriction modifier
Meggezones 16mg pastilles (Schering-Plough Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Meggezones 16mg pastilles (Schering-Plough Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Meggezones 16mg pastilles (Schering-Plough Ltd) Has manufactured dose form Pastille false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Meggezones 16mg pastilles (Schering-Plough Ltd) 24 pastille Is pack of False Meggezones 16mg pastilles (Schering-Plough Ltd) Inferred relationship Existential restriction modifier
Meggezones 16mg pastilles (Schering-Plough Ltd) 24 pastille Has AMP True Meggezones 16mg pastilles (Schering-Plough Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start